Valeant shares jump 6% after analyst says ‘short thesis has been debunked’


Here is the latest Health News from CNBC.

Valeant shares jump 6% after analyst says ‘short thesis has been debunked’
Shares of Valeant rose 6 percent after an analyst who had been bearish on the stock upgraded it.

Concordia shares plunge 27% on slashed outlook, suspended dividend
CXRX shares plunged more than 27 percent after it posted quarterly earnings that missed estimates and replaced their CFO.

Your health insurance costs will go up next year
Turn out your pockets and get ready to pay more for health insurance in 2017.

Valeant shares tumble on report of criminal probe of Philidor unit
Valeant Pharmaceuticals shares fell after The Wall Street Journal reported the company is under federal investigation.

Endo International shares surge after second-quarter earnings top estimates
Endo International shares surged after it posted second-quarter earnings that exceeded analysts expectations and appointed new management.

Valeant maintains full-year forecast, shares jump
Valeant Pharmaceuticals reported quarterly earnings and revenue that fell short of analysts’ expectations on Tuesday.

This is how America’s drug addiction is putting jobs at risk
The opioid drug crisis could become a hurdle for states wooing businesses by touting their great quality of life and workforce.

Get your checkbooks ready: Health providers get hit for shoddy security
Five health-related entities have paid more than $16 million in settlements related to data breaches.

Lab-made mosquito army dispatched to Florida to fight Zika
The U.S. Food and Drug Administration issued its final word on a trial for the genetically-modified Oxitec mosquito.

Bristol clobbered—shares drop 17%—after failed drug test
Shares of Bristol-Myers Squibb briefly fell more than 17 percent in opening trade Friday after its cancer drug failed to meet targets in a late-stage study.

Health system’s 4 million patient data breach leads to biggest settlement ever
Illinois-based Advocate Health Care Network will pay $5.55 million to federal regulators.

Medicare savings are plentiful if you know where to look
If you want to save on Medicare open enrollment, take these steps now.

I’m concerned about Zika impacts we may not be detecting: Doctor
Recent studies suggest the effects of Zika on fetuses may be worse than thought, Dr. Scott Gottlieb says.

Few people have gotten screened so far in United States for Zika virus
Less than 1,500 people in Athenahealth’s cloud network of patient records have been tested for Zika.

Zika fight: Data-fueled effort to get at-risk people tested quickly, stem spread
More than 1,300 patients identified as at-risk of Zika are served by a single health-care facility.

CVS Health is booting some big-name drugs off its coverage list for 2017
CVS Health’s new “excluded” list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.

Biogen shares soar on reports of possible takeover from Merck, Allergan
Biogen shares soared on reports the company has drawn takeover interest from rival companies, the Wall Street Journal said.

Patients skipping meds cost $290 billion per year—can ‘smart’ pills help?
Patients missing out on their medication or taking the wrong dose costs the U.S. health care system $290 billion each year, according to a new report.

Here’s how Theranos CEO plans to lift the lid on its testing methods
Theranos CEO Elizabeth Holmes pledged on Monday to increase transparency regarding its testing methods.

CDC director: Women in the Southern US need to protect themselves from Zika
CDC Director Tom Frieden says pregnant women all over the South should take precautions.

Forget what the dentist said: Medical benefits of dental floss unproven
When the federal government issued its latest dietary guidelines, the flossing recommendation had been removed.

Pfizer beats estimates but maintains 2016 profit forecast
Pfizer’s results were driven by lower taxes and demand for new medicines, but it stuck to its previous sales and profit forecasts for the full year.

CDC: No evidence of a widespread Zika virus in Miami
Florida has identified 10 more cases of Zika virus caused by local mosquitoes and has asked the CDC to send in experts.

3,000% jump in claims: The toll heroin, painkillers take on insurers
Most claims of opioid dependence involved adults between the ages of 19 and 35.

Biogen, Ionis shares rally as muscle drug for infants hits its goal
Biogen and Ionis shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.

Alphabet and GSK create $715 million bioelectronics firm
GlaxoSmithKline and Alphabet’s life sciences unit are creating a new company focused on fighting diseases.

Theranos CEO gets a chance to convince the experts

Be the first to comment on "Valeant shares jump 6% after analyst says ‘short thesis has been debunked’"

Leave a comment

Your email address will not be published.


Time limit is exhausted. Please reload the CAPTCHA.